INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
06 févr. 2024 09h00 HE
|
INmune Bio, Inc.
Boca Raton, Florida, Feb. 06, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as...